Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10012421977
Persistent link: https://www.econbiz.de/10011654277
Persistent link: https://www.econbiz.de/10012423113
Persistent link: https://www.econbiz.de/10011998135
Individual socio-economic status and the respective socio-economic and political contexts are both important determinants of health. Welfare regimes may be linked with health and health inequalities through two potential pathways: first, they may influence the associations between socio-economic...
Persistent link: https://www.econbiz.de/10010783768
The detection of cancer in its early latent stages can improve a patient's chances of recovery and thereby reduce the overall burden of the disease. Cancer screening services are, however, only used by a small part of the population and utilization rates vary widely amongst the 402 German...
Persistent link: https://www.econbiz.de/10011042756
Germany's ruling coalition has recently introduced a new bill to Parliament, the Care Structures Act (CSA), which aims to improve outpatient care supply structures, decentralize decision-making, facilitate cross-sectoral treatment, and strengthen innovation in the nation's health care sector....
Persistent link: https://www.econbiz.de/10011048291
Measures of avoidable deaths incorporate the notion that deaths from certain causes should not occur within specified age groups given effective prevention or timely and appropriate access to health care. The present study investigated the impact on specific types of avoidable cancer deaths...
Persistent link: https://www.econbiz.de/10011048312
All developed nations use indicators to monitor the health of their populations, but few nations provide a systematic monitoring of indicators for small regional units. The present study aims to contribute to the literature a single graph that provides a quick and comprehensive overview of the...
Persistent link: https://www.econbiz.de/10011048316
In the past, free price setting mechanisms in Germany led to high prices of patented pharmaceuticals and to increasing expenditures in the pharmaceutical sector. In order to control patented pharmaceutical prices and to curb increasing pharmaceutical spending, the Act for Restructuring the...
Persistent link: https://www.econbiz.de/10011048324